1 Patients were eligible for enrolment if they were aged 18 yea
2 Patients were eligible for enrolment if they were aged 18 yea
3 Patients were eligible for inclusion as age-matched controls
4 Patients were eligible for inclusion if they had acute ischae
5 Patients were eligible for inclusion if they had chronic HCV
6 Patients were eligible for participation if they had: metasta
7 Patients were eligible for the study if they had advanced-sta
8 Patients were eligible for this matched, retrospective study
9 Patients were eligible for this prospective phase 2 trial if
10 Patients were eligible for this randomised, double-blind, pla
11 Patients were eligible if sufficient tumor characteristics we
12 Patients were eligible if their tumour was either unresectabl
13 Patients were eligible if they had a body-mass index (BMI) be
14 Patients were eligible if they had a diagnosis of glaucoma fr
15 Patients were eligible if they had a Gly551Asp-CFTR mutation
16 Patients were eligible if they had a performance status of 0
17 Patients were eligible if they had a witnessed out-of-hospita
18 Patients were eligible if they had an advanced, histologicall
19 Patients were eligible if they had an ankle-brachial index (A
20 Patients were eligible if they had an ECOG performance status
21 Patients were eligible if they had an HIV diagnosis and began
22 Patients were eligible if they had at least one psychiatric a
23 Patients were eligible if they had chronic lymphocytic leukae
24 Patients were eligible if they had disease progression after
25 Patients were eligible if they had experienced previous treat
26 Patients were eligible if they had measurable disease and had
27 Patients were eligible if they had metastatic colorectal canc
28 Patients were eligible if they had not previously received tr
29 Patients were eligible if they had received one or two previo
30 Patients were eligible if they had stage I to III operable in
31 Patients were eligible if they had symptomatic thrombosis (at
32 Patients were eligible if they met MADIT-II (Multicenter Auto
33 Patients were eligible if they received combination therapy f
34 Patients were eligible if they were 40 to 80 years of age, ha
35 Patients were eligible if they were adults with HIV, who were
36 Patients were eligible if they were age 18 to 70 years with p
37 Patients were eligible if they were aged 0-17 years with 3 or
38 Patients were eligible if they were aged 18 years or more and
39 Patients were eligible if they were aged 18 years or older an
40 Patients were eligible if they were aged 18-80 years, had Par
41 Patients were eligible if they were asymptomatic (score of 0
42 Patients were eligible if they were at least 12 years old wit
43 Patients were eligible if they were at least aged 18 years, h
44 Patients were eligible if they were older than 16 years, had
45 Patients were eligible if they were older than 18 years, able
46 Patients were eligible if they were: >/=18 years old; at risk
47 Patients were eligible regardless of ejection fraction, and w
48 Patients were eligible to be included in the study if they we
49 Patients were eligible to participate if they were aged 20-60
50 Patients were eligible to receive additional cycles of therap